- JP-listed companies
- Astellas Pharma Inc.
- Income statement
Astellas Pharma Inc.【JP:4503】Income statement
Market cap
¥4.05T
P/E ratio
22.3x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 969,387 | 1,005,612 | 1,164,514 | 1,247,259 | 1,372,706 | 1,311,665 | 1,300,316 | 1,306,348 | 1,300,843 | 1,249,528 | 1,296,163 | 1,518,619 | 1,603,672 | 1,912,323 |
| Cost of revenue | - | - | - | 274,321 | 266,857 | 248,208 | 205,735 | 292,050 | 276,739 | 246,063 | 253,009 | 288,353 | 292,485 | 349,206 |
| Gross profit | - | - | - | 360,166 | 382,557 | 381,708 | 407,922 | 1,014,299 | 1,024,104 | 1,003,465 | 1,043,154 | 1,230,266 | 1,311,187 | 1,563,117 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 44,333 | 5,590 | 15,600 | -13,490 | 243,912 | 243,991 | 136,051 | 155,686 | 133,029 | 25,518 | 41,039 |
| Operating expenses | - | - | - | 315,834 | 376,967 | 366,108 | 421,413 | 490,263 | 499,295 | 504,316 | 548,840 | 630,272 | 740,110 | 843,032 |
| Income before tax | 135,108 | 157,156 | 170,792 | 189,683 | 261,770 | 281,769 | 218,113 | 248,967 | 245,350 | 145,324 | 156,886 | 132,361 | 24,969 | 31,237 |
| Provision for income taxes | - | - | - | 15,501 | 1,938 | 9,059 | -5,246 | 26,702 | 49,939 | 24,734 | 32,800 | 33,647 | 7,924 | -19,510 |
| Net income | 37,827 | 92,464 | 90,874 | 135,856 | 193,687 | 218,701 | 164,679 | 222,265 | 195,411 | 120,589 | 124,086 | 98,714 | 17,045 | 50,747 |
| Earnings per share | 169.38 | 40.27 | 41.15 | 61.5 | 89.75 | 103.69 | 81.11 | 115.05 | 104.15 | 64.93 | 67.08 | 54.24 | 9.51 | 28.35 |
| Diluted EPS | 169.17 | 36.03 | 41.08 | 10.99 | 3.69 | 65.26 | 146.04 | 114.94 | 104.08 | 64.9 | 67.05 | 54.09 | 9.47 | 28.24 |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | ||||||
| Dividend per share | 125 | 130 | 135 | 30 | 32 | 34 | 36 | 38 | 40 | 42 | 50 | 60 | 70 | 74 |